🇺🇸 FDA
Pipeline program

EDP-323 Dose Regimen 1

EDP 323-101

Phase 2 small_molecule completed

Quick answer

EDP-323 Dose Regimen 1 for RSV Infection is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ENANTA PHARMACEUTICALS INC
Indication
RSV Infection
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials